Back to Interventions
Substance / Medication

Indacaterol maleate

SNOMED 702802005UMLS C2920417

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Chronic bronchitis
Pulmonary emphysema

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

18 trials linked to this intervention

18
Total Trials
2
Recruiting
5
With Results

Recent Trials

PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

NCT00132938Phase 4Completed5660 enrolled

Inhaled Steroid Reduces Systemic Inflammation in COPD

NCT00175565Phase 4Completed50 enrolled

Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

NCT00181207Phase 4Completed50 enrolled

COPD on Primary Care Treatment (COOPT)

NCT00184977Phase 4Completed270 enrolled

Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD

NCT00538148Phase 4Completed668 enrolled
View all 18 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:
Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.
Beasley Richard W, Donohue James F, Mehta Rajendra et al. · BMJ Open · 2015
PMID: 25649209RCTFull text (PMC)
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Kerwin Edward, Ferguson Gary T, Sanjar Shahin et al. · Lung · 2017
PMID: 28993871Observational
Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.
Prakash Anoop, Babu K Suresh, Morjaria Jaymin B · Int J Chron Obstruct Pulmon Dis · 2015
PMID: 25609944ReviewFull text (PMC)
Formulation of a dry powder for inhalation combining ciclesonide and indacaterol maleate using spray drying.
Bya Laure-Anne, Bottero Benedetta, Coeurderoi Alice et al. · Int J Pharm · 2025
PMID: 40345602Other
Factors Influencing the Dispersibility of Glycopyrronium Bromide and Indacaterol Maleate - Combined In Vitro and In Silico Study.
Rzewińska Aleksandra, Szlęk Jakub, Juszczyk Ewelina et al. · AAPS PharmSciTech · 2025
PMID: 40968339Other
Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan.
Taniguchi Tomoko, Wang Dong, Yoshisue Hajime et al. · Intern Med · 2021
PMID: 33612668OtherFull text (PMC)
Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method.
Zayed Sahar, Belal Fathalla · Chem Cent J · 2017
PMID: 29086816OtherFull text (PMC)
Spectrophotometric and spectrofluorimetric determination of indacaterol maleate in pure form and pharmaceutical preparations: application to content uniformity.
El-Ashry S M, El-Wasseef D R, El-Sherbiny D T et al. · Luminescence · 2015
PMID: 25620654Other
Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration.
Zou Chan, Yang Qian, Yang Shuang et al. · Pulm Pharmacol Ther · 2020
PMID: 32045673Trial
Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients.
Miller David, Vaidya Soniya, Jauernig Juergen et al. · Respir Res · 2020
PMID: 32967685TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Indacaterol maleate (substance)
SNOMED CT
702802005
UMLS CUI
C2920417

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
18
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.